Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.65 |
| ▸ | GLP1R | P43220 | 11/20 | 0.61 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.61 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.61 |
| ▸ | GCGR | P47871 | 8/20 | 0.60 |
| ▸ | GIPR | P48546 | 5/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.59 |
| ▸ | APLNR | P35414 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658369 | 0.95 | CALCR (0.66) | CALCRGLP1RCRHR1CRHR2GCGR | |
| SCHEMBL31182465 | 0.93 | CALCR (0.62) | CALCRGLP1RCRHR1CRHR2GCGR | |
| SCHEMBL30658206 | 0.92 | CALCR (0.68) | CALCRGLP1RCRHR1CRHR2GCGR | |
| SCHEMBL30658294 | 0.88 | CALCR (0.59) | CALCRGLP1RCRHR1CRHR2 | |
| SCHEMBL30658314 | 0.88 | CALCR (0.72) | CALCRGLP1RCRHR1CRHR2GCGR | |
| SCHEMBL30436207 | 0.88 | CALCR (0.59) | CALCRGLP1RCRHR1CRHR2GCGR | |
| SCHEMBL31182812 | 0.88 | NPY2R (0.65) | CALCRGLP1R | |
| SCHEMBL31182500 | 0.87 | CALCR (0.72) | CALCRGLP1RCRHR1CRHR2APLNR | |
| SCHEMBL30658394 | 0.87 | CALCR (0.66) | CALCRGLP1RCRHR1CRHR2GCGR | |
| SCHEMBL31182609 | 0.86 | CALCR (0.71) | CALCRGLP1RCRHR1CRHR2GCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |